ArticleChemical science2019
Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Hybrid Nanoplatforms Based on Photosensitizers and Metal/Covalent Organic Frameworks for Improved Cancer Synergistic Treatment Nano-Delivery Systems.Molecules (Basel, Switzerland) · 2025Review
- Nonemissive Iridium(III) Solvent Complex as a Self-Reporting Photosensitizer for Monitoring Phototherapeutic Efficacy in a "Signal on" Mode.Chemical & biomedical imaging · 2024Article
- NIR-triggered photodynamic therapy of traumatic heterotopic ossification with a type II collagen-targeted photosensitizer.Materials today. Bio · 2023Article
- Visualization of Phototherapy Evolution by Optical Imaging.Molecules (Basel, Switzerland) · 2023Review
- Porphyrin-Based Covalent Organic Frameworks: Design, Synthesis, Photoelectric Conversion Mechanism, and Applications.Biomimetics (Basel, Switzerland) · 2023Review
- Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.Bioactive materials · 2023Review
- Porous Framework Materials for Bioimaging and Cancer Therapy.Molecules (Basel, Switzerland) · 2023Review
- Review
- Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents.Materials (Basel, Switzerland) · 2022Review
- Efficacious and sustained release of an anticancer drug mitoxantrone from new covalent organic frameworks using protein corona.Chemical science · 2022Article
- Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy.Journal of nanobiotechnology · 2022Article
- Recent Progress in Nanoscale Covalent Organic Frameworks for Cancer Diagnosis and Therapy.Nano-micro letters · 2021Review
- Imparting multi-functionality to covalent organic framework nanoparticles by the dual-ligand assistant encapsulation strategy.Nature communications · 2021Article
- A sonosensitiser-based polymeric nanoplatform for chemo-sonodynamic combination therapy of lung cancer.Journal of nanobiotechnology · 2021Article
- A singlet oxygen self-reporting photosensitizer for cancer phototherapy.Chemical science · 2020Article
- Nanoscale covalent organic frameworks as theranostic platforms for oncotherapy: synthesis, functionalization, and applications.Nanoscale advances · 2020Review
- A COF-based nanoplatform for highly efficient cancer diagnosis, photodynamic therapy and prognosis.Chemical science · 2020Article
- Facile Interfacial Synthesis of Densely Spiky Gold Nano-Chestnuts With Full Spectral Absorption for Photothermal Therapy.Frontiers in bioengineering and biotechnology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The real-time and
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.